- 11:45 BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines
- 11:00 Angel’s Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedul
- 10:40 Tigo Energy and Ingeteam Sign Certificate of Compatibility
- 10:30 Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
- 10:00 BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer
Korea Newswire sends your news to the 43,000 journalists in 7,000 media outlets in Korea via our exclusive distribution network.
Korea Newswire sends your news to the world, including 160 countries in 30 languages in partnership with Business Wire.







